Publication | Closed Access
Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms
114
Citations
55
References
2019
Year
Hematological MalignancyNew Therapeutic TargetHypoxia (Medicine)ImmunologyHematologyHypoxia-inducible Factor 1Jak2v617f-positive Myeloproliferative NeoplasmsMedicineCell BiologyTumor BiologyMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1